189 related articles for article (PubMed ID: 7535640)
1. The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
Lung Cancer; 1994 Dec; 11(5-6):353-64. PubMed ID: 7535640
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
Linnoila RI; Mulshine JL; Steinberg SM; Funa K; Matthews MJ; Cotelingam JD; Gazdar AF
Am J Clin Pathol; 1988 Dec; 90(6):641-52. PubMed ID: 2848408
[TBL] [Abstract][Full Text] [Related]
3. Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience.
Linnoila RI; Piantadosi S; Ruckdeschel JC
Chest; 1994 Dec; 106(6 Suppl):367S-371S. PubMed ID: 7988266
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.
Carles J; Rosell R; Ariza A; Pellicer I; Sanchez JJ; Fernandez-Vasalo G; Abad A; Barnadas A
Lung Cancer; 1993 Dec; 10(3-4):209-19. PubMed ID: 7521264
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation in non-small cell lung carcinomas.
Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
[TBL] [Abstract][Full Text] [Related]
6. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.
Graziano SL; Mazid R; Newman N; Tatum A; Oler A; Mortimer JA; Gullo JJ; DiFino SM; Scalzo AJ
J Clin Oncol; 1989 Oct; 7(10):1398-406. PubMed ID: 2550590
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of lung tumors with lung-derived and non-lung-derived monoclonal antibodies.
Ioachim HL; Pambuccian S; Giancotti F; Dorsett B
Int J Cancer Suppl; 1994; 8():132-3. PubMed ID: 7515026
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
Said JW; Vimadalal S; Nash G; Shintaku IP; Heusser RC; Sassoon AF; Lloyd RV
Hum Pathol; 1985 Mar; 16(3):236-40. PubMed ID: 3972403
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A gene expression in non-small cell lung carcinomas.
Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
[TBL] [Abstract][Full Text] [Related]
10. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Kasprzak A; Zabel M; Biczysko W
Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
[TBL] [Abstract][Full Text] [Related]
11. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
Nash SV; Said JW
Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541
[TBL] [Abstract][Full Text] [Related]
12. Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression.
Wertzel H; Grahmann PR; Bansbach S; Lange W; Hasse J; Böhm N
Eur J Cardiothorac Surg; 1997 Nov; 12(5):698-702. PubMed ID: 9458138
[TBL] [Abstract][Full Text] [Related]
13. [Neuroendocrine markers in lung cancer].
Shen L
Zhonghua Bing Li Xue Za Zhi; 1993 Aug; 22(4):201-3. PubMed ID: 8168175
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine differentiation in basal cell carcinoma. An immunohistochemical study.
George E; Swanson PE; Wick MR
Am J Dermatopathol; 1989 Apr; 11(2):131-5. PubMed ID: 2469342
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
[TBL] [Abstract][Full Text] [Related]
16. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
[TBL] [Abstract][Full Text] [Related]
17. The value of immunohistochemical identification of neuroendocrine differentiation in non small cell lung carcinoma.
Słodkowska J
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():23-7. PubMed ID: 9337520
[TBL] [Abstract][Full Text] [Related]
18. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma.
Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y
Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung.
Addis BJ; Hamid Q; Ibrahim NB; Fahey M; Bloom SR; Polak JM
J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings?
Angelsen A; Syversen U; Haugen OA; Stridsberg M; Mjølnerød OK; Waldum HL
Prostate; 1997 Jan; 30(1):1-6. PubMed ID: 9018329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
